Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Nov 27, 2024
Walvax’s PCV13 Officially Exported to India
Learn More
Nov 2, 2023
Walvax publishes data from the Phase 3b trial of Walrinvax™ administered in a reduced dosing regimen among adolescent girls in Vaccine
Learn More
Sep 30, 2022
Walvax and Abogen Granted Indonesian Emergency Use Authorization for the SARS-CoV-2 mRNA Vaccine (AWcorna)
Learn More